Latest Breaking News On - Preclinical data - Page 8 : comparemela.com

EQS-News: Immunic, Inc : Immunic Presents Clinical and Preclinical Data for IMU-856 at Digestive Disease Week 2023, Including Its Molecular Mode of Action

Issuer: Immunic, Inc. / Key word(s): Study/Conference Immunic Presents Clinical and Preclinical Data for IMU-856 at Digestive Disease Week 2023, Including Its Molecular Mode of Action 06.05.2023

United statesPaula schwartzHella kohlhofJessica breuFranziska buriDaniel vittEdna kaplanExchange commissionDistribution servicesImmunic incRx communications groupPresents clinicalPreclinical dataDigestive disease weekIncluding its molecular modeOrally available

Adicet Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Company Pro

Announced interim safety and efficacy data for ADI-001 in ongoing Phase 1 study for the potential treatment of relapsed or refractory B-cell non-Hodgkin’s lymphoma (NHL); Next data update expected in Q2 2023Announced preclinical data for differentiated chimeric antigen receptor (CAR) and chimeric adaptor (CAd) progr.

Adicet bioJanhavi mohiteNancy bomanAnne bowdidgeChen schorAdicet bio incDevelopment rd expensesStern investor relations incSociety for immunotherapy of cancerDrug administrationAnnual meetingChief executive officerRecent operational highlightsEfficacy dataOngoing phasePreclinical data

IGM Biosciences Presents Data from T cell Engager Portfolio for Hematologic Malignancies at 2022 American Society of Hematology Annual Meeting

IGM Biosciences Presents Data from T cell Engager Portfolio for Hematologic Malignancies at 2022 American Society of Hematology Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNew orleansBispecific igChris takimotoDavid pittsAmerican society of hematologyCompany igBiosciences incExchange commissionPreclinical dataPoster presentationsAnnual meetingChief medical officerMyeloma cellsImproved preclinical safetyInvestigational new drug

Ryvu Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Ryvu Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNatalia baranowska ryvuPawel przewiezlikowskiAmerican society of hematologyAmerican societyMenarini groupWarsaw stock exchangeIncentive programAnnual meetingChief executive officerPreclinical dataCancer therapeutics symposiumRyvu therapeuticsLoss attributableCommon shareholdersJohn frauncesrelationship

Plus Therapeutics (PSTV) Provides Updates on ReSPECT Clinical Trials

Plus Therapeutics (PSTV) Provides Updates on ReSPECT Clinical Trials
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAndrewj brennerNorman lafranceEducation day of the society for neuroTherapeutics incWall streetAnnual scientific meetingEducation dayTexas health science centerSan antonioDose escalation trialRecurrent gliomaConvection enhanced deliveryPlanned phasePreclinical dataInitial clinical experience